Cargando…

A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers()

BACKGROUND: High risk human papillomavirus (HR-HPV) infection is common and only a small minority of infections become persistent and lead to cervical cancers. Women positive for HR-HPV usually require a second test to avoid unnecessary colposcopies and over treatment. Elevated DNA methylation of HR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasiljević, Nataša, Scibior-Bentkowska, Dorota, Brentnall, Adam, Cuzick, Jack, Lorincz, Attila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969303/ https://www.ncbi.nlm.nih.gov/pubmed/24468012 http://dx.doi.org/10.1016/j.jcv.2013.12.014

Ejemplares similares

Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women
por: Vasiljević, Nataša, et al.
Publicado: (2014)

A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes
por: Brentnall, Adam R, et al.
Publicado: (2014)

Validation of a DNA methylation HPV triage classifier in a screening sample
por: Lorincz, Attila T., et al.
Publicado: (2016)

HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology
por: Lorincz, Attila T, et al.
Publicado: (2013)

Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping
por: Hernández-López, Rubí, et al.
Publicado: (2019)

DNA methylation testing with S5 for triage of high‐risk HPV positive women
por: Adcock, Rachael, et al.
Publicado: (2022)

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
por: Bee, Katharine J., et al.
Publicado: (2021)

Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions
por: Lorincz, Attila T., et al.
Publicado: (2017)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Searching HPV genome for methylation sites involved in molecular progression to cervical precancer
por: Kottaridi, Christine, et al.
Publicado: (2019)

Need for expanded HPV genotyping for cervical screening()
por: Cuzick, Jack, et al.
Publicado: (2016)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus–Based Screening in Mexico
por: Torres-Ibarra, Leticia, et al.
Publicado: (2019)

Risk Factors for Cervical Precancer and Cancer in HIV-Infected, HPV-Positive Rwandan Women
por: Anastos, Kathryn, et al.
Publicado: (2010)

Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial
por: Cook, Darrel A., et al.
Publicado: (2018)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later
por: Inturrisi, Federica, et al.
Publicado: (2022)

Screening for High-Risk Oral Human Papillomavirus (HPV31, HPV33, HPV35) in a Multi-Racial Pediatric and Adult Clinic Patient Population
por: Hinton, Hunter, et al.
Publicado: (2023)

Molecular progression to cervical precancer, epigenetic switch or sequential model?
por: Nedjai, Belinda, et al.
Publicado: (2018)

HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer
por: Amaro-Filho, Sérgio Menezes, et al.
Publicado: (2018)

Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70
por: Chen, Zigui, et al.
Publicado: (2013)

Evaluating operational parameters of the careHPV, GeneXpert, AmpFire, and MA-6000 HPV systems for cervical precancer screening: Experience from Battor, Ghana
por: Effah, Kofi, et al.
Publicado: (2023)

Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix(®) or Gardasil(®) Vaccine
por: Godi, Anna, et al.
Publicado: (2015)

Single Nucleotide Polymorphisms in the PRDX3 and RPS19 and Risk of HPV Persistence and Cervical Precancer/Cancer
por: Safaeian, Mahboobeh, et al.
Publicado: (2012)

The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10–16 years
por: Nakalembe, Miriam, et al.
Publicado: (2014)

HPV genotype distribution and anomalous association of HPV33 to cervical neoplastic lesions in San Luis Potosí, Mexico
por: DelaRosa-Martínez, Raúl, et al.
Publicado: (2016)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix
por: Long, Wenbo, et al.
Publicado: (2018)

The Interpretive Variability of Cervical Biopsies and Its Relationship to HPV Status
por: Stoler, Mark H., et al.
Publicado: (2015)

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
por: Arbyn, Marc, et al.
Publicado: (2018)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

HPV testing of self-samples: Influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer
por: Arbyn, Marc, et al.
Publicado: (2022)

Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination
por: Song, Fangbin, et al.
Publicado: (2022)

Cervical precancer screening with HPV DNA testing and mobile colposcopy in women with sickle cell disease in Accra, Ghana
por: Dei-Adomakoh, Yvonne, et al.
Publicado: (2023)

HPV testing in primary screening of older women
por: Cuzick, J, et al.
Publicado: (1999)

HPV Genotype Specific and Age Stratified Immediate Prevalence of Cervical Precancers and Cancers in Women with NILM/hrHPV+: A Single Center Retrospective Study of 26,228 Cases
por: Liu, Qin, et al.
Publicado: (2021)

Risk of cervical precancer among HPV–negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study
por: Inturrisi, Federica, et al.
Publicado: (2022)

Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain
por: Pérez, Sonia, et al.
Publicado: (2014)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f941g82h18frt2p2103ecci0ge